- Home
- DVS vs STIM Comparison
DVS vs STIM Comparison
Compare DVS & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DVS
- STIM
- Stock Information
- Founded
- DVS 2011
- STIM 2003
- Country
- DVS Canada
- STIM United States
- Employees
- DVS N/A
- STIM N/A
- Industry
- DVS
- STIM Medical/Dental Instruments
- Sector
- DVS
- STIM Health Care
- Exchange
- DVS Nasdaq
- STIM Nasdaq
- Market Cap
- DVS 210.3M
- STIM 232.3M
- IPO Year
- DVS N/A
- STIM 2018
- Fundamental
- Price
- DVS $3.65
- STIM $3.56
- Analyst Decision
- DVS
- STIM Buy
- Analyst Count
- DVS 0
- STIM 4
- Target Price
- DVS N/A
- STIM $6.00
- AVG Volume (30 Days)
- DVS 313.9K
- STIM 936.2K
- Earning Date
- DVS 08-23-2025
- STIM 08-11-2025
- Dividend Yield
- DVS N/A
- STIM N/A
- EPS Growth
- DVS N/A
- STIM N/A
- EPS
- DVS N/A
- STIM N/A
- Revenue
- DVS N/A
- STIM $89,448,000.00
- Revenue This Year
- DVS N/A
- STIM $105.22
- Revenue Next Year
- DVS N/A
- STIM $11.89
- P/E Ratio
- DVS N/A
- STIM N/A
- Revenue Growth
- DVS N/A
- STIM 22.16
- 52 Week Low
- DVS $2.48
- STIM $0.52
- 52 Week High
- DVS $4.00
- STIM $5.92
- Technical
- Relative Strength Index (RSI)
- DVS N/A
- STIM 46.24
- Support Level
- DVS N/A
- STIM $3.18
- Resistance Level
- DVS N/A
- STIM $3.60
- Average True Range (ATR)
- DVS 0.00
- STIM 0.21
- MACD
- DVS 0.00
- STIM 0.03
- Stochastic Oscillator
- DVS 0.00
- STIM 86.00
About DVS Dolly Varden Silver Corporation Common Shares
Dolly Varden Silver Corp is a mineral exploration company. The company's primary business is the acquisition, exploration, evaluation, and development of exploration and evaluation assets. It is focused on exploration advancing the Kitsault Valley Project, which includes the Dolly Varden property and the Homestake Ridge property located in the Golden Triangle of British Columbia, Canada.
About STIM Neuronetics Inc.
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.